Literature DB >> 21400535

A reconstruction with extracorporeal irradiated autograft in osteosarcoma around the knee.

Jae-Do Kim1, Gun Woo Lee, So Hak Chung.   

Abstract

BACKGROUND AND OBJECTIVES: An extracorporeal irradiated (ECI) autograft was first reported in Israel in 1968 for the treatment of primary malignant bone tumor. However, subsequent reports covered mostly short-term follow up results, and the reported results of reconstruction vary from study to study. We analyze the long-term follow up results of reconstruction using an extracorporeal irradiated (ECI) autograft in osteosarcoma around the knee.
METHODS: We retrospectively reviewed 23 osteosarcoma patients who underwent reconstruction with ECI between December 1995 and April 2005. The 15 males and 8 females had a mean age of 21 years (range: 7-74) and a mean follow-up of 127 months(range: 57-170). Tumors were located in the distal femur in 14 cases, and the proximal tibia in 9 cases. Pathological types were conventional in 22 cases, and parosteal in 1 case. Resection methods were osteoarticular in 18 cases and total joint in 5 cases. Eighteen cases were reconstructed with the ECI autograft and five with ECI autograft-prosthesis composite (APC). The Musculoskeletal Tumor Society (MSTS) score was used for functional evaluation. The overall survival rate, local recurrence, complications were analyzed.
RESULTS: The overall survival rate was 82.6%, and the disease-free survival rate was 69.5%. We found 20 complications, including 6 nonunions, 5 deep infections, 4 joint instabilities, 2 fractures, 1 limb-length discrepancy (LLD), 1 epiphyseal collapse, and 1 vessel occlusion. The average MSTS functional score was 62.6%.
CONCLUSIONS: Reconstruction with an extracorporeal irradiated is not recommended for osteosarcoma around the knee.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21400535     DOI: 10.1002/jso.21902

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Knee joint preservation surgery in osteosarcoma using tumour-bearing bone treated with liquid nitrogen.

Authors:  Takashi Higuchi; Norio Yamamoto; Hideji Nishida; Katsuhiro Hayashi; Akihiko Takeuchi; Hiroaki Kimura; Shinji Miwa; Hiroyuki Inatani; Shingo Shimozaki; Takashi Kato; Yu Aoki; Kensaku Abe; Yuta Taniguchi; Hiroyuki Tsuchiya
Journal:  Int Orthop       Date:  2017-06-01       Impact factor: 3.075

2.  Limb Salvage Using Liquid Nitrogen-Treated Tumour-Bearing Autograft: A Single Institutional Experience of 10 Patients.

Authors:  Sudhir Kumar Garg; Purnima Aggarwal; Jagandeep Virk; R P S Punia; Kislay Dimri; Rohit Jindal
Journal:  Indian J Orthop       Date:  2020-01-13       Impact factor: 1.251

3.  A patient with scapular Ewing sarcoma; 5-year follow-up after extracorporeal irradiation and re-implantation of the scapula, a case report.

Authors:  Daniel Hoornenborg; Ewout S Veltman; Foppe Oldenburger; Jos A M Bramer; Gerard R Schaap
Journal:  J Bone Oncol       Date:  2013-01-08       Impact factor: 4.072

4.  Surgical outcomes of extracorporeal irradiation and re-implantation in extremities for high grade osteosarcoma: A retrospective cohort study and a systematic review of the literature.

Authors:  Dumnoensun Pruksakorn; Jatupon Kongthavonskul; Pimpisa Teeyakasem; Areerak Phanphaisarn; Parunya Chaiyawat; Jeerawan Klangjorhor; Olarn Arpornchayanon
Journal:  J Bone Oncol       Date:  2018-12-10       Impact factor: 4.072

5.  Hip-preserving reconstruction of the proximal femur with a vascularized fibula autograft and liquid-nitrogen-treated tumor bearing bone.

Authors:  Mehmet Ayvaz; Barlas Göker; Gürsel Leblebicioğlu
Journal:  Jt Dis Relat Surg       Date:  2021-11-19

6.  Computer-aided resection and endoprosthesis design for the management of malignant bone tumors around the knee: outcomes of 12 cases.

Authors:  Huan-wen Ding; Guang-wen Yu; Qiang Tu; Bao Liu; Jian-jian Shen; Hong Wang; Ying-jun Wang
Journal:  BMC Musculoskelet Disord       Date:  2013-11-22       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.